NCT05456087Phase 2Active, not recruiting
Use of Botulinum Toxin in the Treatment of Androgenic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Active, not recruiting
- Declared phase
- Phase 2
- Sponsor
- Zel Skin and Laser Specialists
- Participants (registry)
- 20
- Start
- August 2022
- Primary completion
- December 2024
- Study completion
- December 2024
- Last registry update
- March 2024
- Countries
- United States
Conditions studied: Androgenetic Alopecia
Interventions: incobotulinumtoxin A, Xeomin
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.